Help us to name the fourth theme of our refreshed research strategy

Share Help us to name the fourth theme of our refreshed research strategy on Facebook Share Help us to name the fourth theme of our refreshed research strategy on Twitter Share Help us to name the fourth theme of our refreshed research strategy on Linkedin Email Help us to name the fourth theme of our refreshed research strategy link

Consultation has concluded, thank you for all your ideas!

The Institute of Cancer Research and Royal Marsden are refreshing the current research strategy. A group of public contributors have been involved in this work already and have provided input into the detailed strategy text.

Part of this refresh includes new theme names, and we are seeking ideas and suggestions for the name of the fourth theme. We have not yet successfully found a strong name for the fourth theme and are therefore seeking input from patients and the public to help us. The revised strategy will build on our existing research strategy, find it here.

Our potential new themes are as follows:

Theme 1: Fundamental Science. This Theme is focused on understanding how cancers behave to improve our knowledge of cancer development and inform the other themes of our strategy.

Theme 2: Innovative Diagnostics. This Theme covers research into earlier, faster and more precise ways of diagnosing cancer. We aim to develop more digital and advanced methods to detect the disease earlier, to determine the best personalised treatment and identify initial signs of recurrence or resistance.

Theme 3: Precision Therapies – In this Theme we will exploit our understanding of cancer to create better treatments for local and metastatic disease and test them in patients for the first time.

Theme 4 will focus on late-stage clinical studies that provide the evidence to support the routine use of new diagnostics and treatments in the NHS and across the world. The theme will also research tailored supportive strategies to improve the experiences of patients along the whole pathway of cancer care.

Please add your ideas for what we should name Theme 4, that are in line with the other Themes names, in the ideas board below. We would like most ideas by 20th November, so we could discuss them at the Research Strategy Board on 25th November 2024.


The Institute of Cancer Research and Royal Marsden are refreshing the current research strategy. A group of public contributors have been involved in this work already and have provided input into the detailed strategy text.

Part of this refresh includes new theme names, and we are seeking ideas and suggestions for the name of the fourth theme. We have not yet successfully found a strong name for the fourth theme and are therefore seeking input from patients and the public to help us. The revised strategy will build on our existing research strategy, find it here.

Our potential new themes are as follows:

Theme 1: Fundamental Science. This Theme is focused on understanding how cancers behave to improve our knowledge of cancer development and inform the other themes of our strategy.

Theme 2: Innovative Diagnostics. This Theme covers research into earlier, faster and more precise ways of diagnosing cancer. We aim to develop more digital and advanced methods to detect the disease earlier, to determine the best personalised treatment and identify initial signs of recurrence or resistance.

Theme 3: Precision Therapies – In this Theme we will exploit our understanding of cancer to create better treatments for local and metastatic disease and test them in patients for the first time.

Theme 4 will focus on late-stage clinical studies that provide the evidence to support the routine use of new diagnostics and treatments in the NHS and across the world. The theme will also research tailored supportive strategies to improve the experiences of patients along the whole pathway of cancer care.

Please add your ideas for what we should name Theme 4, that are in line with the other Themes names, in the ideas board below. We would like most ideas by 20th November, so we could discuss them at the Research Strategy Board on 25th November 2024.